The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 265 of the 267 references it cites were found in a registry or an index.
Abstract
Immune checkpoint inhibitors (ICI) have led to profound and durable tumor regression in some patients with metastatic cancer diseases. However, many patients still do not derive benefit from immunotherapy. Here, the accumulation of immunosuppressive cell populations within the tumor microenvironment (TME), such as myeloid-derived suppressor cells (MDSC), tumor-associated macrophages (TAM), and regulatory T cells (Treg), contributes to the development of immune resistance. MDSC and Treg expand systematically in tumor patients and inhibit T cell activation and T effector cell function. Numerous studies have shown that the immunosuppressive mechanisms exerted by those inhibitory cell populations comprise soluble immunomodulatory mediators and receptor interactions. The latter are also required for the crosstalk of MDSC and Treg, raising questions about the relevance of cell–cell contacts for the establishment of their inhibitory properties. This review aims to outline the current knowledge on the crosstalk between these two cell populations, issuing particularly the potential role of cell adhesion molecules. In this regard, we further discuss the relevance of β2 integrins, which are essential for the differentiation and function of leukocytes as well as for MDSC–Treg interaction. Lastly, we aim to describe the impact of such bidirectional crosstalk for basic and applied cancer research and discuss how the targeting of these pathways might pave the way for future approaches in immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Myeloid cell plasticity in cancer. Myeloid cell types originate from hematopoietic stem cells and multipotent immature myeloid progenitor cells in the bone marrow (BM). The differentiation toward the matured cell line (i.e., polymorphonuclear neutrophils (PMN)) is promoted by soluble mediators and chemokines. In cancer patients, the differentiation pathways are strongly affected by factors produced in the tumor microenvironment (TME) by stromal cells, immune cells, and tumor cells (e.g., granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-1β, IL-6, IL-10, IL-23, interferon-gamma (IFN-γ)). In particular, the TME promotes the polarization of macrophages toward immunosuppressive tumor-associated macrophages (TAM), which confer the inhibition of effector T cells (Teff) within the TME via various mechanisms [72]. PMN within the TME frequently show a polarization toward immunosuppressive TAN, which is driven by soluble factors such as transforming growth factor-β (TGF-β). Tumor-associated neutrophils (TAN) confer immunosuppression via multiple mechanisms. The most prominent effect of the aberrant differentiation includes the accumulation of granulocytic (G-MDSC) and monocytic (M-MDSC) myeloid-derived suppressor cells. Myeloid cells may act as an integrated system in the context of tumor immunity [49]. Depending on the structural composition of the TME, myeloid cells polarize from MDSC toward TAM or TAN or promote the tolerization of DC in the context of a nutrient-depleted, hypoxic, inflamed TME. Under normoxic conditions, IFN-γ and TNF-α have been found to reverse this polarization and promote MDSC differentiation toward immunogenic DC and inflammatory M1 macrophages. It remains questioned if MDSC and TAN undergo an irreversible polarization or can polarize to anti-tumor PMN [24].](https://figures.cochat.ai/paper-figures/b2217f656d3048098235e4ff91d84e33/the-functional-crosstalk-between-myeloid-derived-suppressor-cells-and-regulatory-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIF activation within solid tumors leads to the release of chemokines that promote the recruitment of immunosuppressive cell types such as tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), and regulatory T cell (Treg) cells, which can limit the anti-tumor activity of Natural Killer and CD8 + T cells (Figure 1) [67].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [67]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MDSCs attenuate anti-tumor immunity particularly the activity of T cells, by secreting factors such as arginase-1 (Arg-1), inducible nitric oxide synthase (iNOS), and reactive oxygen species (ROS), thereby facilitating tumor cells to evade immune surveillance [27].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–265 of 265
Carlino, M. S., Long, G. V., Schadendorf, D., Robert, C., Ribas, A., Richtig, E., Nyakas, M., Caglevic, C., Tarhini, A., Blank, C. U., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.06.034 · Cited by 110
Sorrentino, C., Miele, L., Porta, A., Pinto, A., & Morello, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4393 · Cited by 107 · cited 1×
“With regard to the role of β2-integrins for tumor neovascularization, Soloviev and coworkers found that CD11b−/− mice displayed an impaired infiltration of myeloid cells in the tumor tissue, subsequently resulting in an attenuated VEGF secretion and thus attenuated neovascularization [231,232].”
BackgroundSchouppe, E., Mommer, C., Movahedi, K., Laoui, D., Morias, Y., Gysemans, C., Luyckx, A., De Baetselier, P., & Van Ginderachter, J. A. (2013) · European Journal of Immunology · doi:10.1002/eji.201343349 · Cited by 104 · cited 1×
“Lastly, it has been documented that MDSC counteract the upregulation of CD44 and CD162 by T cells in an NO-dependent manner, thus impairing T cell extravasation and tissue infiltration [103,104].”
BackgroundNagaraj, S., Nelson, A., Youn, J.-I., Cheng, P., Quiceno, D., & Gabrilovich, D. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2863 · Cited by 103
Urlaub, D., Höfer, K., Müller, M.-L., & Watzl, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601004 · Cited by 103 · cited 1×
“Moreover, β2 integrins are critically involved in the differentiation of immune cells [196], the migration into inflammatory tissues [197], as well as the extent and character of immune responses.”
BackgroundEffects of CD18 Deficiency on the Emigration of Murine Neutrophils During Pneumonia
Mizgerd, J. P., Horwitz, B. H., Quillen, H. C., Scott, M. L., & Doerschuk, C. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.995 · Cited by 101 · cited 1×
“pneumoniae [225] and Aspergillus fumigatus [226], whereas the recruitment and migration into infected lungs was not affected.”
BackgroundSeyerl, M., Kirchberger, S., Majdic, O., Seipelt, J., Jindra, C., Arnold‐Schrauf, C., & Stöckl, J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939527 · Cited by 101 · cited 1×
“Notably, the combination signals transduced by PD-L1 and CD169 on MDSC were found to be essential for an induction of IL-35-producing nTreg [162].”
BackgroundSalmi, S., Siiskonen, H., Sironen, R. K., Tyynelä-Korhonen, K., Hirschovits-Gerz, B., Valkonen, M., Auvinen, P., & Pasonen‐Seppänen, S. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000522 · Cited by 101 · cited 20×
“Moreover, β2 integrins play a pivotal role in the communication of tumor cells and myeloid cells (e.g., MDSC, TAM, and PMN) within the TME [247], which induce tolerance and thus support tumor growth and progression.”
BackgroundInfluentialRole of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
DeVito, N. C., Plebanek, M. P., Theivanthiran, B., & Hanks, B. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02876 · Cited by 100
CD18 Is Required for Optimal Development and Function of CD4+CD25+ T Regulatory Cells
Marski, M., Kandula, S., Turner, J. R., & Abraham, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.7889 · Cited by 95 · cited 1×
“Further, T cells resembling nTreg according to their phenotype, derived from CD11a−/− mice, conferred a diminished suppressive activity on stimulated naïve T cells [203,204].”
BackgroundThe Dendritic Cell Synapse: A Life Dedicated to T Cell Activation
Benvenuti, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00070 · Cited by 95 · cited 1×
“Although recent reports have focused on other immune cell interactions mediated by β2 integrins, such as the establishment of the immunological synapse between APC and T cells [248], it seems plausible that β2”
BackgroundMyeloid derived suppressor cells and their role in tolerance induction in cancer
Fujimura, T., Mahnke, K., & Enk, A. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.05.001 · Cited by 92 · cited 1×
“Here, the depletion of MDSC led to a significant reduction of intratumoral Treg, thus confirming, that MDSC have the ability to promote the de novo generation and recruitment of Treg [21,152].”
BackgroundHypomethylation and overexpression of ITGAL (CD11a) in CD4+ T cells in systemic sclerosis
Wang, Y., Shu, Y., Xiao, Y., Wang, Q., Kanekura, T., Li, Y., Wang, J., Zhao, M., Lu, Q., & Xiao, R. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-25 · Cited by 88 · cited 1×
“In accordance with these findings, the importance of LFA-1, expressed on T cells, for the induction of tolerance and the suppression of inflammation has been documented in various autoimmune diseases, such as experimental autoimmune encephalitis (EAE) [208,209], systemic sclerosis [210,211], rheumatoid arthritis, psor…”
ResultTwo may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer
Page, D. B., Bear, H., Prabhakaran, S., Gatti-Mays, M. E., Thomas, A., Cobain, E., McArthur, H., Balko, J. M., Gameiro, S. R., Nanda, R., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0130-x · Cited by 84 · cited 1×
“Additional immunotherapeutic agents, including drugs that target either checkpoint molecules, such as TIM-3 [261], LAG3 [176], or VISTA [262] or immune-metabolic checkpoints such as adenosine (A2A-receptor antagonist, CD73 or CD39 inhibitors) and IDO, yielded promising results in preclinical tumor models [263–265] and…”
BackgroundFoubert, P., Kaneda, M. M., & Varner, J. A. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0143 · Cited by 82
Keilholz, U., Mehnert, J. M., Bauer, S., Bourgeois, H., Patel, M. R., Gravenor, D., Nemunaitis, J. J., Taylor, M. H., Wyrwicz, L., Lee, K.-W., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0459-y · Cited by 82
Centuori, S. M., Trad, M., LaCasse, C. J., Alizadeh, D., Larmonier, C. B., Hanke, N. T., Kartchner, J., Janikashvili, N., Bonnotte, B., Larmonier, N., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0911465 · Cited by 80
β2 integrins are required for skin homing of primed T cells but not for priming naive T cells
Grabbe, S., Varga, G., Beissert, S., Steinert, M., Pendl, G., Seeliger, S., Bloch, W., Peters, T., Schwarz, T., Sunderkötter, C., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci11703 · Cited by 77
Self-citationPruijt, J. F. M., van Kooyk, Y., Figdor, C. G., Lindley, I. J. D., Willemze, R., & Fibbe, W. E. (1998) · Blood · doi:10.1182/blood.v91.11.4099 · Cited by 77
Papayannopoulou, T., Priestley, G. V., Nakamoto, B., Zafiropoulos, V., Scott, L. M., & Harlan, J. M. (2001) · Blood · doi:10.1182/blood.v97.5.1282 · Cited by 75 · cited 10×
“In order to exert immunosuppressive functions, Treg express high levels of ICAM-1, P-Selectin, and the integrin a4b1 (very late antigen-4; VLA-4) allowing the quick migration to the site of inflammation [217].”
BackgroundInfluentialWei, T., Zhang, J., Qin, Y., Wu, Y. C., Zhu, L. X., Lu, L., Tang, G., & Shen, Q. (2015) · Europe PMC (PubMed Central) · Cited by 75
Extracellular adenosine metabolism in immune cells in melanoma
Umansky, V., Shevchenko, I., Bazhin, A. V., & Utikal, J. S. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1553-8 · Cited by 73 · cited 2×
“Hence, the proliferation, activation, and retention of highly immunosuppressive MDSC are not only induced by the chronic inflammatory state within the TME, but it further enhances these conditions, thus creating a positive feedback loop [34,51].”
BackgroundSingh, K., Gatzka, M., Peters, T., Borkner, L., Hainzl, A., Wang, H., Sindrilaru, A., & Scharffetter-Kochanek, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202399 · Cited by 69 · cited 2×
“These observations suggest an important role of β2 integrins in Treg differentiation and function [204].”
BackgroundMyeloid cells in the tumor microenvironment: Role of adenosine
Morello, S., Pinto, A., Blandizzi, C., & Antonioli, L. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1108515 · Cited by 68 · cited 18×
“ADO serves as a potent immunosuppressive molecule, inhibiting effector immune cell populations via different adenosine receptors (A1, A2A, A2B, and A3).”
BackgroundResultInfluentialWang, H., Peters, T., Sindrilaru, A., Keß, D., Oreshkova, T., Yu, X., Seier, A. M., Schreiber, H. A., Wlaschek, M., Blakytny, R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34916 · Cited by 67 · cited 9×
“Here, it has been found that PMN from LAD-1 patients have indeed not been able to suppress the proliferation of T cells, whereas CD18-expressing PMN could effectively suppress T cell proliferation, while ROS production and degranulation were intact in both PMN populations.”
BackgroundInfluentialLFA-1 Contributes to Signal I of T-Cell Activation and to the Production of Th1 Cytokines
Varga, G., Nippe, N., Balkow, S., Peters, T., Wild, M. K., Seeliger, S., Beissert, S., Krummen, M., Roth, J., Sunderkötter, C. H., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.398 · Cited by 67 · cited 1×
“Here, observations indicated that the interaction between LFA-1 on DC and T cell expressed ICAM-1 lowered the threshold required for T cell stimulation [201].”
BackgroundSelf-citationWatanabe, T., Davé, B. J., Heimann, D., Lethaby, E., Kessinger, A., & Talmadge, J. E. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700814 · Cited by 64
Köstlin‐Gille, N., Dietz, S., Schwarz, J., Spring, B., Pauluschke‐Fröhlich, J., Poets, C. F., & Gille, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00161 · Cited by 62 · cited 1×
“This observation is in line with the finding that MDSC produce pro-angiogenic factors and proteases that endorse angiogenesis and metastases of tumors [164] and that β2 integrins are particularly upregulated on MDSC in hypoxic tissues [233].”
ResultGuttman‐Yassky, E., Vugmeyster, Y., Lowes, M. A., Chamian, F., Kikuchi, T., Kagen, M. H., Gilleaudeau, P., Lee, E., Hunte, B., Howell, K., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.4 · Cited by 61 · cited 1×
“In accordance with these findings, the importance of LFA-1, expressed on T cells, for the induction of tolerance and the suppression of inflammation has been documented in various autoimmune diseases, such as experimental autoimmune encephalitis (EAE) [208,209], systemic sclerosis [210,211], rheumatoid arthritis, psor…”
ResultWeiss, J. M., Subleski, J. J., Back, T., Chen, X., Watkins, S. K., Yagita, H., Sayers, T. J., Murphy, W. J., & Wiltrout, R. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400404 · Cited by 60 · cited 1×
“Moreover, it has been reported that a combination treatment of IL-2 and agonistic CD40 antibodies elicited synergistic anti-tumor immune responses coincident with the depletion of both Treg and MDSC in primary renal cell carcinomas [192].”
BackgroundApproved checkpoint inhibitors in bladder cancer: which drug should be used when?
Ghatalia, P., Zibelman, M. R., Geynisman, D. M., & Plimack, E. R. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918788310 · Cited by 58
Harder, N., Schönmeyer, R., Nekolla, K., Meier, A., Brieu, N., Vanegas, C., Madonna, G., Capone, M., Botti, G., Ascierto, P. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43525-8 · Cited by 56 · cited 2×
“However, a large number of cancer patients do not derive benefit from ICI therapy, which is presumably due to an intrinsic or acquired resistance [2].”
BackgroundLFA-1 is critical for regulatory T cell homeostasis and function
Wohler, J. E., Bullard, D. C., Schoeb, T. R., & Barnum, S. R. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.004 · Cited by 55 · cited 2×
“Notably, both LFA-1 and Mac-1 have been implicated in Treg [207] and MDSC induction [246] and survival.”
BackgroundOhl, K., Fragoulis, A., Klemm, P., Baumeister, J., Klock, W., Verjans, E., Böll, S., Möllmann, J., Lehrke, M., Costa, I., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01552 · Cited by 55 · cited 2×
“On the other hand, MDSC themselves are protected from the cytotoxic ROS effects by induction of the antioxidant nuclear factor erythroid related factor 2 (Nrf2) and the accumulation of the ROS scavenger phosphoenolpyruvate (PEP) [100].”
BackgroundCD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
Zhang, Q.-Q., Hu, X.-W., Liu, Y.-L., Ye, Z.-J., Gui, Y.-H., Zhou, D.-L., Qi, C.-L., He, X.-D., Wang, H., & Wang, L.-J. (2015) · Scientific Reports · doi:10.1038/srep15948 · Cited by 54 · cited 2×
“Accordingly, Zhang and coworkers reported that CD11b−/− mice showed a reduced infiltration of myeloid cells in intestinal adenoma and an attenuated tumor growth [229].”
BackgroundModern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
Petrova, V., Arkhypov, I., Weber, R., Groth, C., Altevogt, P., Utikal, J. S., & Umansky, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072367 · Cited by 54 · cited 1×
“Notably, more recent observations revealed the pivotal role of additional checkpoint molecules, such as the V domain-containing immunoglobulin suppressor of T-cell activation (VISTA), Galectin-9 (Gal-9), and CD155 for MDSC-mediated immunosuppression [112].”
BackgroundAngiari, S., Rossi, B., Piccio, L. M., Zinselmeyer, B. H., Budui, S. L., Zenaro, E., Bianca, V. D., Bach, S., Scarpini, E. A., Bolomini‐Vittori, M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301235 · Cited by 52 · cited 1×
“Consequently, PSGL-1 might enhance the migration of either cell type into inflamed tissues [245] and also promote immunosuppressive properties via the ligation of VISTA (see Section 4).”
BackgroundGlatigny, S., Duhen, R., Arbelaez, C., Kumari, S., & Bettelli, E. (2015) · Scientific Reports · doi:10.1038/srep07834 · Cited by 51
Chouaïb, S., Umansky, V., & Kiéda, C. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.73874 · Cited by 51 · cited 1×
“together, hypoxic conditions, which are characteristic for the TME, induced the accumulation of MDSC and Treg at the tumor site, stimulated Treg induction, and produced the capacities of both cell types to effectively inhibit the anti-tumor responses by reinforcing their functional crosstalk [169].”
BackgroundP-selectin glycoprotein ligand-1 in T cells
Abadier, M., & Ley, K. F. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000331 · Cited by 49 · cited 1×
“, ICAM-1) can be enhanced via the ligation of PSGL-1 [193], which is expressed on both MDSC and Treg [244].”
BackgroundNarita, Y., Wakita, D., Ohkur, T., Chamoto, K., & Nishimura, T. (2009) · Biomedical Research · doi:10.2220/biomedres.30.7 · Cited by 48
Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors
Olbryt, M., Rajczykowski, M., & Widłak, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114071 · Cited by 48 · cited 1×
“More interestingly, the extent of Treg infiltration into human tumors has been proposed to show an inverse correlation with the response to ICI therapy [131,132].”
BackgroundLeukocyte arrest: Biomechanics and molecular mechanisms of β 2 integrin activation
Fan, Z., & Ley, K. F. (2016) · Biorheology · doi:10.3233/bir-15085 · Cited by 48 · cited 8×
“Moreover, β2 integrins are critically involved in the differentiation of immune cells [196], the migration into inflammatory tissues [197], as well as the extent and character of immune responses. β2 integrins interact with various surface receptors, e.g., intercellular adhesion molecules (ICAM15), vascular cell adhes…”
BackgroundInfluentialThe integrin αMβ2 anchors hematopoietic progenitors in the bone marrow during enforced mobilization
Hidalgo, A., Peired, A. J., Weiss, L. A., Katayama, Y., & Frenette, P. S. (2004) · Blood · doi:10.1182/blood-2003-10-3702 · Cited by 47
Green, K. A., Wang, L., Noelle, R. J., & Green, W. R. (2015) · Journal of Virology · doi:10.1128/jvi.00888-15 · Cited by 46 · cited 1×
“In particular, VISTA has been reported to enhance the inhibition of T cell [113,114] and B cell responses [115] by MDSC, whereas a blockade of VISTA allowed for the restoration of a protective anti-tumor response [116,117].”
BackgroundCD11b regulates the Treg/Th17 balance in murine arthritis via IL‐6
Stevanin, M., Busso, N., Chobaz, V., Pigni, M., Ghassem‐Zadeh, S., Zhang, L., Acha‐Orbea, H., & Ehirchiou, D. (2017) · European Journal of Immunology · doi:10.1002/eji.201646565 · Cited by 46 · cited 1×
“Next to CD11a, CD11b might be involved in the regulation of the Treg/Th 17 balance as well [205].”
BackgroundMorello, S., & Miele, L. (2014) · OncoImmunology · doi:10.4161/onci.27989 · Cited by 45 · cited 2×
“First, ADO prevents the maturation of MDSC via A2B-receptor (A2BR) stimulation.”
BackgroundSpira, A. I., Hamid, O., Bauer, T. M., Borges, V. F., Wasser, J. S., Smith, D. C., Clark, A. S., Schmidt, E. V., Zhao, Y., Maleski, J. E., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.1103 · Cited by 43
Cao, L. Y., Soler, D. C., Debanne, S., Grozdev, I., Rodríguez, M. E., Feig, R. L., Carman, T. L., Gilkeson, R., Orringer, C. E., Kern, E. F. O., et al. (2013) · Europe PMC (PubMed Central) · Cited by 42
Regulatory T cells induce CD4− NKT cell anergy and suppress NKT cell cytotoxic function
Ihara, F., Sakurai, D., Takami, M., Kamata, T., Kunii, N., Yamasaki, K., Iinuma, T., Nakayama, T., Motohashi, S., & Okamoto, Y. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02417-6 · Cited by 39 · cited 1×
“of their T cell stimulatory capacity [130,147].”
Gültner, S., Kuhlmann, T., Hesse, A., Weber, J. P., Riemer, C., Baier, M., & Hutloff, A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040576 · Cited by 36 · cited 1×
“In accordance with these findings, the importance of LFA-1, expressed on T cells, for the induction of tolerance and the suppression of inflammation has been documented in various autoimmune diseases, such as experimental autoimmune encephalitis (EAE) [208,209], systemic sclerosis [210,211], rheumatoid arthritis, psor…”
ResultMaccalli, C., Giannarelli, D., Capocefalo, F., Pilla, L., Fonsatti, E., Giacomo, A. M. D., Parmiani, G., & Maio, M. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1071007 · Cited by 33 · cited 1×
“, the frequency, composition, and activation status [9,10] of tumor-infiltrating lymphocytes (TIL), are predictive for the responsiveness toward ICI treatment.”
BackgroundThe Role of Macrophage 1 Antigen in Polymicrobial Sepsis
Liu, J., Han, X., Soriano, S. G., & Yuki, K. (2014) · Shock · doi:10.1097/shk.0000000000000250 · Cited by 33 · cited 2×
“However, these mice showed higher bacterial counts and a stronger systemic inflammation, which is indicative of the attenuated killing activity of CD11b-deficient leukocytes [224].”
BackgroundLuo, Y., Wang, Y., Shu, Y., Lu, Q., & Xiao, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.023 · Cited by 32 · cited 1×
“In accordance with these findings, the importance of LFA-1, expressed on T cells, for the induction of tolerance and the suppression of inflammation has been documented in various autoimmune diseases, such as experimental autoimmune encephalitis (EAE) [208,209], systemic sclerosis [210,211], rheumatoid arthritis, psor…”
ResultTeschner, D., Cholaszczyńska, A., Ries, F., Beckert, H., Theobald, M., Grabbe, S., Radsak, M. P., & Bros, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00123 · Cited by 32
Self-citationStrategies for Predicting Response to Checkpoint Inhibitors
Zappasodi, R., Wolchok, J. D., & Merghoub, T. (2018) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-018-0471-9 · Cited by 31 · cited 1×
“, a high mutational load of the tumor cells [3,4], the presence of neoantigens [5,6], microsatellite instability [7,8], and host factors, i.”
BackgroundLFA-1 decreases the antigen dose for T cell activation in vivo
Wang, Y., Shibuya, K., Yamashita, Y., Shirakawa, J., Shibata, K., Kai, H., Yokosuka, T., Saito, T., Honda, S.-I., Tahara‐Hanaoka, S., et al. (2008) · International Immunology · doi:10.1093/intimm/dxn070 · Cited by 30 · cited 1×
“Thus, β2 integrin deficiency resulted in elevated thresholds for TCR activation and subsequently promoted tolerance in vitro and in vivo [202].”
BackgroundPeyvandi, S., Buart, S., Samah, B., Vétizou, M., Zhang, Y., Durrieu, L., Polrot, M., Chouaïb, S., Benihoud, K., Louache, F., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1848 · Cited by 30 · cited 1×
“Despite conflicting reports about the role of Fas-(L)igand-Fas signaling for MDSC homeostasis and function [90,123], it is well documented that MDSC are able to induce T cell apoptosis via FasL [124].”
BackgroundNeumann, K., Ostmann, A., Breda, P. C., Ochel, A., Tacke, F., Paust, H., Panzer, U., & Tiegs, G. (2019) · Scientific Reports · doi:10.1038/s41598-018-38432-3 · Cited by 30 · cited 1×
“PD-L1 exerts its effects via ligation of PD-1 on T cells, resulting in T cell anergy and apoptosis [104], promoting the induction and function of Treg [107] and thus contributing to tumor immune evasion.”
BackgroundDual Role of the Leukocyte Integrin αMβ2 in Angiogenesis
Soloviev, D. A., Hazen, S. L., Szpak, D., Bledzka, K. M., Ballantyne, C. M., Plow, E. F., & Pluskota, E. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400202 · Cited by 29
Gensterblum‐Miller, E., Renauer, P. A., Coit, P., Strickland, F. M., Kilian, N. C., Miller, S. D., Ognenovski, M., Wren, J. D., Tsou, P., Lewis, E. E., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.09.011 · Cited by 24 · cited 1×
“In accordance with these findings, the importance of LFA-1, expressed on T cells, for the induction of tolerance and the suppression of inflammation has been documented in various autoimmune diseases, such as experimental autoimmune encephalitis (EAE) [208,209], systemic sclerosis [210,211], rheumatoid arthritis, psor…”
ResultProtein tyrosine phosphatase PTPN22 regulates LFA-1 dependent Th1 responses
Sanchez-Blanco, C., Clarke, F., Cornish, G. H., Depoil, D., Thompson, S. J., Dai, X., Rawlings, D. J., Dustin, M. L., Zamoyska, R., Cope, A. P., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.008 · Cited by 22 · cited 1×
“Notably, in most of these diseases, expression levels of CD11a on T cells inversely correlated with the severity of the disease [213,215,216].”
BackgroundHaasken, S., Auger, J. L., & Binstadt, B. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000967 · Cited by 20
Lian, M., Zhang, J., Zhao, L., Chen, X., Peng, Y., Wang, Q., Chen, S., & Ma, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02577 · Cited by 18 · cited 1×
“In another report, IL-35, a heterodimer of EBV-induced gene 3 (EBI3) and of IL-12p35, has been identified as an inhibitory cytokine generated by nTreg, which promoted IL-10 secretion and CD39 expression by iTreg, and NO production in MDSC [160,161].”
BackgroundKoboziev, I., Karlsson, F. J., Ostanin, D. V., Gray, L. T., Davidson, M., Zhang, S., & Grisham, M. B. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22947 · Cited by 12 · cited 1×
“In accordance with these findings, the importance of LFA-1, expressed on T cells, for the induction of tolerance and the suppression of inflammation has been documented in various autoimmune diseases, such as experimental autoimmune encephalitis (EAE) [208,209], systemic sclerosis [210,211], rheumatoid arthritis, psor…”
Result
Cited by
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 460
“In addition, Treg cells in the TME convert ATP into adenosine, inhibiting the activity of immune cells in tumors (Lindau et al., 2013; Peixoto et al., 2019; Haist et al., 2021).”
BackgroundAdvances on immunotherapy for osteosarcoma
Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270
He, S., Zheng, L., & Qi, C. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02208-3 · Cited by 227
Exploiting innate immunity for cancer immunotherapy
Yi, M., Li, T., Niu, M., Mei, Q., Zhao, B., Chu, Q., Dai, Z., & Wu, K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01885-w · Cited by 225
Metadata
- Authors
- Haist, M., Stege, H., Grabbe, S., & Bros, M.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Haist, Maximilian
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-01-08
- Volume
- 13
- Issue
- 2
- Pages
- 210
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC7827203
- OpenAlex
- W3119068311
- Cited by
- 295
- References
- 267
- Citations by year
- 2026: 100 · 2025: 69 · 2024: 42 · 2023: 35 · 2022: 32 · 2021: 17
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Else Kröner Fresenius Foundation (TransMed Jumpstart Program: 2019_A72)
- Deutsche Forschungsgemeinschaft (SFB_1066 (B4,B5), TR156 (B11))
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- myeloid-derived suppressor cells, regulatory T cells, tumor microenvironment, immunosuppression, immune checkpoint inhibitors, immune resistance, cell-cell crosstalk, adhesion molecules, beta2 integrins, tumor-associated macrophages, immunotherapy targets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.